Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 4.51 · gapped above the open, then crossed back over prior close. High/low 4.69 at 7:45 am ET, 4.42 at 11:00 am ET.
Prelude Therapeutics Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
77 institutional managers report a position in Prelude Therapeutics Inc worth $266.0M between them, filed on form 13F for the quarter ending 2026-06-30. 7 of them hold 80% of it, the largest being Orbimed Advisors LLC at 27.50%.
52 more managers in the register
7 managers hold 80% of the $266.0M institutional base. The other 70 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Orbimed Advisors LLC, RA Capital Management, LLC, Acadian Asset Management LLC +1 more · 27.50% of PRLD, 18.40% of QTTB
via Orbimed Advisors LLC, RA Capital Management, LLC, Adage Capital Partners GP, L.L.C. +2 more · 27.50% of PRLD, 13.71% of ACET
via Orbimed Advisors LLC, Sphera Funds Management Ltd., ADAR1 Capital Management, LLC +2 more · 27.50% of PRLD, 19.54% of TRAW
via Orbimed Advisors LLC, RA Capital Management, LLC, Baker Bros. Advisors LP +2 more · 27.50% of PRLD, 12.96% of EWTX
via Baker Bros. Advisors LP, Adage Capital Partners GP, L.L.C., Kynam Capital Management, LP +1 more · 20.29% of PRLD, 22.99% of SMMT
via Baker Bros. Advisors LP, Acadian Asset Management LLC, Marshall Wace LLP · 20.29% of PRLD, 28.87% of BCYC
Managers holding a meaningful stake in PRLD also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
PRLD (Prelude Therapeutics Inc) has 2 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: JEF −2.47%, in financials.